Cancer, Physical Activity, Fatigue
Conditions
Brief summary
The overall goal of the present trial is to evaluate the patients' compliance for wearing a commercially available fitness tracker during and after oncological treatments.
Interventions
DEVICEFitness Tracker
Patients will continuously wear a commercially available fitness tracker which will collect data on physical activity (steps), pulse rate and sleep behaviour.
Sponsors
University Hospital Tuebingen
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Histologically confirmed malignant disease * Upcoming chemotherapy of radiochemotherapy * Eastern Co-operative Oncology Group (ECOG) performance score 0-2
Exclusion criteria
* Pre-existing comorbidities that impair patient mobility. * Eastern Co-operative Oncology Group (ECOG) performance score 3-4
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Compliance for wearing the fitness tracker | Four weeks after the end of radiotherapy | Based on the read outs from the fitness trackers we will calculate the percentage of the days on which the tracker was worn, which is defined as the compliance. |
Countries
Germany
Contacts
Primary ContactCihan Gani, MD
Backup ContactSilke Theden
Outcome results
None listed